You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行报告》瑞银:京东健康(06618.HK)去年业绩胜预期 料市场反应正面
阿思达克 03-30 11:32
瑞银发表报告表示,京东健康(06618.HK)去年业绩胜预期,指去年下半年收入106亿人民币按年升81%、去年收入录194亿人民币按年升79%,分别高於该行原预期各14%及7%,处方药、非处方药及医疗设备增长强劲,盈利能力亦优於该行预期。

该行指,京东健康去年毛利率25.4%、净利润率3.5%,均优於该行原预期各24.8%及2.5%,指公司去年下半年业绩表现均强於该行原先预期,并估计市场会对京东健康去年业绩反应正面。

而瑞银维持京东健康「中性」评级及目标价150元,此相当今年预测市销率16倍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account